FDA Increases Foreign CGMP Inspections in 2023
The FDA significantly increased foreign inspections in fiscal 2023 while domestic inspections remained flat, according to the agency’s latest annual inspection report.
Source: Drug Industry Daily
The FDA significantly increased foreign inspections in fiscal 2023 while domestic inspections remained flat, according to the agency’s latest annual inspection report.
Source: Drug Industry Daily